Why the heart and liver benefit, even without direct targets Habegger says one of the most striking findings from large clinical trials is that GLP-1 drugs reduce the risk of heart attacks, strokes and cardiovascular death
As well as an increase in the practical use of sportswear for exercise purposes, there may be a rush to join the athleisure craze as suggested by a BMO Capital Markets analysis
Critically it provided the first evidence of the 'posttranslational processing of a polypeptide precursor into the mature functional form of the hormone by specialized proteolytic enzymes'
Interestingly, supplementation of metformin with 1.5 mg dulaglutide per week in the treatment of T2MD in obese patients with severe impairment of glycosylated hemoglobin A1c (HbA1c) was reported to bring lasting benefits in the control of glucose metabolism and body weight (173)
The increasing incidence of lifestyle-related diseases in the Asia Pacific is increasing the demand for GLP-1 drugs
*** Use of sustained-release glucocorticoid formulations may result in detectable glucocorticoid levels past the washout period due to prolonged systemic absorption